In fulfilment of one of its objectives to meet the health needs of its members, the Ghana National Association of Teachers (GNAT) passed a resolution to authorize the deduction of Two Ghana Cedis (GHC2.00) from each member per month, to fund the treatment of any member who suffers cancer.
The treatment goes for all cancers, apart from blood-related cancers. The Fund which operates on the principle of insurance, covers a member, his/her spouse, and two children below eighteen (18) years of age.
The Fund is in collaboration with the Sweden Ghana Medical Centre (SGMC), a state-of-the-art oncology centre for the treatment of cancer. Through sensitization and the many testimonies from members who have undergone treatment and the smiles that it has brought to many families, more people are benefiting from the Fund, now than ever before.
Since its inception in 2014, to December 2020, a total of Six Thousand, Seven Hundred and Seventy-three (6,773) GNAT members have received treatment under the Fund. Out of this number, Three Thousand, Nine Hundred and Fifty-two (3,952) have been fully treated. It is important to note that the cost of treating one cancer patient ranges from Forty-Five Thousand Ghana Cedis (GHC45,000.00) to Two Hundred and Fifty Thousand Ghana Cedis (GHC250,000.00)
The Ghana National Association of Teachers (GNAT) has purchased and is now the proud owner of the Sweden Ghana Medical Centre (SGMC). In a statement on the purchase, Messrs. Global Medical Investments AB (GMI) has officially announced that the Ghana National Association of Teachers (GNAT) has successfully concluded its purchase of the SGMC, from them. Sweden Ghana Medical Centre is the leading and first private cancer care centre of excellence in West Africa.
SGMC covers the full range of cancer specialties; with a highly skilled team that uses state-of-the-art equipment and European-standard treatment techniques to provide high-quality radiation treatment. In addition, the Centre uses modern virtual simulation and CT-based 3D treatment planning capabilities, aimed at precisely targeting radiation delivery to tumours, while protecting normal tissues.